At SofiaSante, we are pioneering the next generation of pharmaceutical solutions through cutting-edge drug development and advanced delivery technologies. Our mission is to create innovative therapies that address critical unmet medical needs, improving patient outcomes with smarter, more effective treatments.
A key focus of our research is the development of novel combination therapies and next-generation drug delivery systems. In collaboration with CSIRO, we are advancing a revolutionary trans-dermal drug delivery platform designed for needleless administration of therapeutics. This technology enhances drug absorption, improves patient compliance, and unlocks new possibilities for targeted treatment.
Currently, we are developing breakthrough therapies for weight loss, diabetes, resistant forms of erectile dysfunction, and lipid disorders. By integrating innovative drug formulations with state-of-the-art delivery mechanisms, we strive to develop transformative treatments that enhance patient care and improve therapeutic outcomes.
At SofiaSante, we are committed to redefining the future of medicine. Join us in our journey to drive meaningful change in healthcare and create lasting value for patients and investors alike. Together, we can bring innovation to life!
Chief Executive Officer, SofiaSante Pharmaceuticals
Berk Toluk is the Chief Executive Officer of SofiaSante Pharmaceuticals. Under his leadership, SofiaSante is advancing a pipeline of innovative treatments, including novel transdermal drug delivery systems developed in close collaboration with the CSIRO. He has led the company’s capital raising initiatives, secured strategic partnerships, and positioned the business at the forefront of next-generation obesity therapeutics.
A seasoned legal practitioner with over 12 years of experience, Berk has held senior executive positions across government, healthcare, and private practice. His career includes serving as Principal Lawyer (Commercial) at Queensland Health (Metro South Health Service), where he provided strategic legal advice on clinical trials/translational research, commercial contracts, and health law matters for the Executive Leadership Team and Health Service Board. He also worked as Principal Legal Officer at the Queensland Department of the Premier and Cabinet, and as Principal Lawyer at Crown Law, Queensland. Earlier in his career, he founded and managed Toluk Legal, specializing in commercial law and civil litigation.
Berk also brings entrepreneurial experience as the Founder and Managing Director of Castawall Australia, where he led R&D initiatives for the development of a next generation construction system, intellectual property management, licensing, and commercialization activities. This combination of legal expertise and business leadership gives him a unique ability to integrate scientific innovation with governance and commercial execution.
Beyond law and biotechnology, Berk holds postgraduate qualifications in Applied Finance, which strengthen his commercial acumen and support his work in leading capital raising initiatives and complex financial negotiations.
Outside of his professional pursuits, Berk is an avid wildlife photographer, with a keen eye for capturing the natural world. This passion reflects his curiosity, patience, and appreciation for detail: qualities that also define his professional approach.
With a career bridging healthcare, law, and entrepreneurship, Berk Toluk is committed to advancing innovative health solutions, building sovereign capability in Australia, and ensuring legal and ethical integrity in all aspects of his work.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.